$DNMR
Danimer Scientific, Inc.

2023 Q2 Form 10-Q Financial Statement

#000095017023020673 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $12.87M $11.93M $14.74M
YoY Change 1.28% -19.11% 11.85%
Cost Of Revenue $19.43M $18.21M $16.07M
YoY Change 48.82% 13.35% 37.01%
Gross Profit -$6.568M -$6.283M -$1.322M
YoY Change 1750.14% 375.26% -190.8%
Gross Profit Margin -51.05% -52.68% -8.97%
Selling, General & Admin $16.84M $18.70M $22.24M
YoY Change -25.76% -15.91% 119.72%
% of Gross Profit
Research & Development $7.709M $7.075M $7.131M
YoY Change -6.97% -0.79% 172.28%
% of Gross Profit
Depreciation & Amortization $7.173M $7.579M $4.259M
YoY Change 65.7% 77.95% 102.81%
% of Gross Profit
Operating Expenses $24.55M $25.77M $29.37M
YoY Change -22.7% -12.23% 130.53%
Operating Profit -$31.12M -$32.23M -$30.69M
YoY Change -3.11% 5.01% 171.99%
Interest Expense -$8.079M -$4.502M $992.0K
YoY Change -694.04% -553.83% 570.27%
% of Operating Profit
Other Income/Expense, Net -$8.181M -$4.502M $4.012M
YoY Change -11008.0% -212.21% -104.81%
Pretax Income -$39.30M -$36.73M -$26.68M
YoY Change 28.08% 37.68% -71.84%
Income Tax -$100.0K -$100.0K -$291.0K
% Of Pretax Income
Net Earnings -$39.24M -$36.64M -$26.39M
YoY Change 28.89% 38.86% -72.15%
Net Earnings / Revenue -305.02% -307.22% -178.97%
Basic Earnings Per Share -$0.38 -$0.36 -$0.26
Diluted Earnings Per Share -$0.38 -$0.36 -$262.0K
COMMON SHARES
Basic Shares Outstanding 101.9M 101.9M 100.8M
Diluted Shares Outstanding 101.9M 101.9M 100.7M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.77M $102.0M $210.0M
YoY Change -35.34% -51.44% -32.87%
Cash & Equivalents $90.77M $102.0M $210.0M
Short-Term Investments
Other Short-Term Assets $5.441M $21.80M $4.059M
YoY Change 0.87% 437.05% -11.76%
Inventory $29.87M $31.75M $28.23M
Prepaid Expenses $5.441M $4.186M $4.059M
Receivables $13.00M $16.09M $18.83M
Other Receivables $1.481M $1.561M $1.378M
Total Short-Term Assets $145.4M $178.5M $266.8M
YoY Change -28.05% -33.11% -22.84%
LONG-TERM ASSETS
Property, Plant & Equipment $454.1M $455.1M $364.6M
YoY Change 6.1% 24.82% 181.4%
Goodwill $62.66M
YoY Change
Intangibles $79.33M $80.12M $83.58M
YoY Change -4.14% 4637.98%
Long-Term Investments
YoY Change
Other Assets $344.0K $226.0K $228.0K
YoY Change -83.54% -0.88% 212.33%
Total Long-Term Assets $598.9M $600.1M $545.6M
YoY Change 1.73% 9.99% 227.76%
TOTAL ASSETS
Total Short-Term Assets $145.4M $178.5M $266.8M
Total Long-Term Assets $598.9M $600.1M $545.6M
Total Assets $744.3M $778.6M $812.5M
YoY Change -5.88% -4.16% 58.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.558M $6.218M $17.08M
YoY Change -69.71% -63.59% 58.16%
Accrued Expenses $4.985M $7.147M $14.04M
YoY Change -62.41% -49.1% 83.51%
Deferred Revenue $0.00 $0.00
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.847M $6.719M $218.0K
YoY Change -17.62% 2982.11% -36.81%
Total Short-Term Liabilities $14.60M $24.73M $34.67M
YoY Change -52.3% -28.66% 43.35%
LONG-TERM LIABILITIES
Long-Term Debt $376.0M $373.5M $261.5M
YoY Change 43.49% 42.85% 734.91%
Other Long-Term Liabilities $1.083M $1.326M $526.0K
YoY Change -95.79% 152.09% -43.92%
Total Long-Term Liabilities $1.083M $1.326M $526.0K
YoY Change -99.62% 152.09% -98.37%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.60M $24.73M $34.67M
Total Long-Term Liabilities $1.083M $1.326M $526.0K
Total Liabilities $414.0M $423.0M $324.5M
YoY Change 29.83% 30.35% 41.08%
SHAREHOLDERS EQUITY
Retained Earnings -$374.5M -$335.3M -$145.3M
YoY Change 130.79% -5.37%
Common Stock $10.00K $10.00K $10.00K
YoY Change 0.0% 11.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $330.3M $355.6M $487.9M
YoY Change
Total Liabilities & Shareholders Equity $744.3M $778.6M $812.5M
YoY Change -5.88% -4.16% 58.59%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$39.24M -$36.64M -$26.39M
YoY Change 28.89% 38.86% -72.15%
Depreciation, Depletion And Amortization $7.173M $7.579M $4.259M
YoY Change 65.7% 77.95% 102.81%
Cash From Operating Activities -$15.29M -$5.865M -$17.61M
YoY Change -22.75% -66.69% 23.91%
INVESTING ACTIVITIES
Capital Expenditures $6.641M $16.40M $58.90M
YoY Change -113.3% -72.16% 146.52%
Acquisitions $0.00 $14.00K
YoY Change -100.0%
Other Investing Activities $0.00 $0.00 -$14.00K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$6.641M -$16.40M -$58.92M
YoY Change -86.69% -72.16% 146.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $5.494M $44.00K
YoY Change 12386.36% -99.84%
Cash From Financing Activities -6.510M 91.54M 78.00K
YoY Change 92900.0% 117257.69% -100.29%
NET CHANGE
Cash From Operating Activities -15.29M -5.865M -17.61M
Cash From Investing Activities -6.641M -16.40M -58.92M
Cash From Financing Activities -6.510M 91.54M 78.00K
Net Change In Cash -28.44M 69.27M -76.44M
YoY Change -59.19% -190.62% 18.21%
FREE CASH FLOW
Cash From Operating Activities -$15.29M -$5.865M -$17.61M
Capital Expenditures $6.641M $16.40M $58.90M
Free Cash Flow -$21.93M -$22.27M -$76.51M
YoY Change -172.7% -70.9% 100.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
DANIMER SCIENTIFIC, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-1924518
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
140 Industrial Boulevard
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bainbridge
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
39817
CY2023Q1 dei City Area Code
CityAreaCode
229
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
243-7075
CY2023Q1 dei Security12b Title
Security12bTitle
Class A Common stock, $0.0001 par value per share
CY2023Q1 dei Trading Symbol
TradingSymbol
DNMR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dnmr Warrants Issued With Senior Secured Term Loan
WarrantsIssuedWithSeniorSecuredTermLoan
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001779020
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-39280
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
101938376
CY2022Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
286398000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
107000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
200000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
101991000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62792000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
17613000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16086000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
17989000
CY2023Q1 us-gaap Other Receivables
OtherReceivables
1561000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1635000
CY2023Q1 us-gaap Inventory Net
InventoryNet
31745000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32743000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4186000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5225000
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
5312000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4687000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
178494000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
125071000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455132000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453949000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80115000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80941000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19147000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19028000
CY2023Q1 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2022Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31446000
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
14071000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1609000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
226000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
226000
CY2023Q1 us-gaap Assets
Assets
778631000
CY2022Q4 us-gaap Assets
Assets
712270000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6218000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
14977000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7147000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5001000
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
1313000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
0
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3337000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6719000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1972000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
24734000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25287000
CY2023Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
1328000
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
212000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22036000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22114000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1326000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
447000
CY2023Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
373484000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-36639000
CY2023Q1 us-gaap Liabilities
Liabilities
423015000
CY2022Q4 us-gaap Liabilities
Liabilities
334658000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101938376
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
101804454
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101804454
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
10000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
10000
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
690893000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
676250000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-335287000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-298648000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
355616000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
377612000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
778631000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
712270000
CY2023Q1 us-gaap Revenues
Revenues
11926000
CY2022Q1 us-gaap Revenues
Revenues
14743000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
18209000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
16065000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18699000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22236000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7075000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7131000
CY2023Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
-170000
CY2022Q1 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
44153000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
45432000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-32227000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-30689000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1116000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4995000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3386000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-992000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4502000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4012000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-36729000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26677000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-90000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-291000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-26386000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
878000
CY2022Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-111000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101896326
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101896326
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100728366
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100728366
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
355616000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
487947000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-36639000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-26386000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
14065000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13750000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7579000
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4259000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1116000
CY2022Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4995000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
828000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
572000
CY2023Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
519000
CY2022Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
-595000
CY2023Q1 dnmr Inventory Reserves
InventoryReserves
244000
CY2022Q1 dnmr Inventory Reserves
InventoryReserves
1056000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-92000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-291000
CY2023Q1 dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-196000
CY2022Q1 dnmr Amortization Of Right Of Use Assets And Lease Liability
AmortizationOfRightOfUseAssetsAndLeaseLiability
-77000
CY2023Q1 us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-170000
CY2022Q1 us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
0
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-17000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2422000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2272000
CY2023Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-74000
CY2022Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2458000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-753000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4713000
CY2023Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1039000
CY2022Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-678000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
625000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
729000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0
CY2022Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1256000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
725000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2981000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1923000
CY2023Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1313000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-214000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
14071000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5865000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17605000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16400000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
58902000
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
14000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16400000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58916000
CY2023Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
130000000
CY2022Q1 us-gaap Proceeds From Repayments Of Other Long Term Debt
ProceedsFromRepaymentsOfOtherLongTermDebt
0
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
33035000
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
196000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5494000
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
44000
CY2023Q1 dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
129000
CY2022Q1 dnmr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
209000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
164000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
61000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2023Q1 dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
0
CY2022Q1 dnmr Payments Related To Warrants Costs
PaymentsRelatedToWarrantsCosts
55000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
91539000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
78000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
69274000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-76443000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64401000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
286968000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133675000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
210525000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
2942000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
420000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
929000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
885000
CY2023Q1 dnmr Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment
ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment
-8337000
CY2022Q1 dnmr Changes In Accounts Payable And Accrued Liabilities Related To Purchase Of Property Plant And Equipment
ChangesInAccountsPayableAndAccruedLiabilitiesRelatedToPurchaseOfPropertyPlantAndEquipment
7251000
CY2023Q1 dnmr Warrants Issued With Senior Secured Term Loan
WarrantsIssuedWithSeniorSecuredTermLoan
510000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2023Q1 us-gaap Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
85500000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
17613000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1609000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
101991000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
62792000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133675000
CY2022Q4 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
415000
CY2023Q1 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
239000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64401000
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
16079000
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
19964000
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
1754000
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1524000
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13912000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11255000
CY2023Q1 us-gaap Inventory Net
InventoryNet
31745000
CY2022Q4 us-gaap Inventory Net
InventoryNet
32743000
CY2023Q1 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
6300000
CY2022Q4 dnmr Finished Neat Pha Included In Finished Goods
FinishedNeatPhaIncludedInFinishedGoods
4900000
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
200000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
506364000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
498814000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
51232000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
44865000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455132000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
453949000
CY2022Q4 dnmr Construction In Progress Accrued Liabilities
ConstructionInProgressAccruedLiabilities
1089000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
7579000
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
4259000
CY2023Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
204513000
CY2022Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
198545000
CY2023Q1 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
14700000
CY2022Q4 us-gaap Accumulated Capitalized Interest Costs
AccumulatedCapitalizedInterestCosts
14600000
CY2023Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
100000
CY2022Q1 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1600000
CY2023Q1 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P18Y2M12D
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94668000
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
94291000
CY2023Q1 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-1905000
CY2022Q4 dnmr Intangible Assets Not Yet Amortized
IntangibleAssetsNotYetAmortized
-1604000
CY2023Q1 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92763000
CY2022Q4 dnmr Amortization Intangible Assets Gross
AmortizationIntangibleAssetsGross
92687000
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14553000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13350000
CY2023Q1 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
78210000
CY2022Q4 dnmr Amortization Intangible Assets Net
AmortizationIntangibleAssetsNet
79337000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80115000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
80941000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1200000
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
2405000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
134000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1667000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
443000
CY2023Q1 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
984000
CY2022Q4 dnmr Accrued Compensation And Related Liabilities
AccruedCompensationAndRelatedLiabilities
1305000
CY2023Q1 dnmr Other Accrued Taxes
OtherAccruedTaxes
871000
CY2022Q4 dnmr Other Accrued Taxes
OtherAccruedTaxes
669000
CY2023Q1 us-gaap Accrued Utilities Current And Noncurrent
AccruedUtilitiesCurrentAndNoncurrent
378000
CY2023Q1 dnmr Purchase Accrual
PurchaseAccrual
0
CY2022Q4 dnmr Purchase Accrual
PurchaseAccrual
401000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
603000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
545000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7147000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5001000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-100000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.002
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.011
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
794000
CY2022Q1 dnmr Operating Lease Expense Benefit Net
OperatingLeaseExpenseBenefitNet
887000
CY2023Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P16Y
CY2023Q1 dnmr Incremental Borrowing Rate Percentage
IncrementalBorrowingRatePercentage
0.144
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
100000
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
3914525
CY2023Q1 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2021-05-07
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101938376
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
422866000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
298317000
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
42663000
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
9947000
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
6719000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1972000
CY2023Q1 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
373484000
CY2022Q4 dnmr Long Term Debt Net Of Current Maturities And Debt Issuance Costs
LongTermDebtNetOfCurrentMaturitiesAndDebtIssuanceCosts
286398000
CY2021Q4 dnmr Convertible Senior Notes Due Year
ConvertibleSeniorNotesDueYear
2026
CY2021Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
10.79
CY2023Q1 us-gaap Repayments Of Subordinated Debt
RepaymentsOfSubordinatedDebt
4600000
CY2023Q1 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31400000
CY2022Q4 dnmr Leverage Loans Receivable
LeverageLoansReceivable
31400000
CY2022Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0399
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
6719000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
104000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
250000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
261071000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
130014000
CY2023Q1 dnmr Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
24708000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
422866000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101804454
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100687820
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
133922
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
72395
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100760215
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125489
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
125489
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
42104570
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40239037
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
100000
CY2022Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
200000
CY2023Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3600000
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3400000
CY2022Q4 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
2765000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2021Q4 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
2128000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
214000
CY2023Q1 dnmr Contract With Customer Assets Revenue Recognized
ContractWithCustomerAssetsRevenueRecognized
589000
CY2023Q1 dnmr Contract With Customer Liability Revenue Recognized1
ContractWithCustomerLiabilityRevenueRecognized1
0
CY2022 dnmr Contract With Customer Assets Revenue Recognized
ContractWithCustomerAssetsRevenueRecognized
3446000
CY2022 dnmr Contract With Customer Liability Revenue Recognized1
ContractWithCustomerLiabilityRevenueRecognized1
2364000
CY2023Q1 dnmr Contract With Customer Asset Consideration Received
ContractWithCustomerAssetConsiderationReceived
0
CY2023Q1 dnmr Contract With Customer Liability Consideration Received
ContractWithCustomerLiabilityConsiderationReceived
0
CY2022 dnmr Contract With Customer Asset Consideration Received
ContractWithCustomerAssetConsiderationReceived
-1594000
CY2022 dnmr Contract With Customer Liability Consideration Received
ContractWithCustomerLiabilityConsiderationReceived
-2150000
CY2023Q1 dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
0
CY2023Q1 dnmr Contract With Customer Liabilities Reserves Recorded
ContractWithCustomerLiabilitiesReservesRecorded
0
CY2022 dnmr Contract With Customer Asset Reserves Recorded
ContractWithCustomerAssetReservesRecorded
-1215000
CY2022 dnmr Contract With Customer Liabilities Reserves Recorded
ContractWithCustomerLiabilitiesReservesRecorded
0
CY2023Q1 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
3354000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2022Q4 dnmr Contract With Customer Asset Current
ContractWithCustomerAssetCurrent
2765000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0
CY2023Q1 us-gaap Revenues
Revenues
11926000
CY2022Q1 us-gaap Revenues
Revenues
14743000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
14943000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
13700000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11844644
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.23
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M15D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
204254
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.58
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4667
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
12044231
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.04
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M23D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
852617000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4497424
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.85
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y14D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
679266000
CY2023Q1 dnmr Share Based Compensation Arrangement By Share Based Payment Award Options Vested Number Of Shares Vested And Expected To Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumberOfSharesVestedAndExpectedToVest
12044231
CY2023Q1 dnmr Weighted Average Exercise Price Vested And Expected To Vest
WeightedAverageExercisePriceVestedAndExpectedToVest
14.04
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y5M23D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
852617000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.17
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
1.77
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
49200000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2023Q1 dnmr Royalty Per Share
RoyaltyPerShare
0.05
CY2023Q1 dnmr Weights Of Pha Sold
WeightsOfPhaSold
500000000
CY2023Q1 dnmr Decrease Royalty Per Share
DecreaseRoyaltyPerShare
0.025
CY2023Q1 dnmr Prepaid Royalties Loss On Forfeiture
PrepaidRoyaltiesLossOnForfeiture
500000

Files In Submission

Name View Source Status
dnmr-20230331_pre.xml Edgar Link unprocessable
0000950170-23-020673-index-headers.html Edgar Link pending
0000950170-23-020673-index.html Edgar Link pending
0000950170-23-020673.txt Edgar Link pending
0000950170-23-020673-xbrl.zip Edgar Link pending
dnmr-20230331.htm Edgar Link pending
dnmr-20230331.xsd Edgar Link pending
dnmr-ex31_1.htm Edgar Link pending
dnmr-ex31_2.htm Edgar Link pending
dnmr-ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
dnmr-20230331_cal.xml Edgar Link unprocessable
dnmr-20230331_def.xml Edgar Link unprocessable
dnmr-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dnmr-20230331_htm.xml Edgar Link completed
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending